Publicaciones en las que colabora con Leire Arbea Moreno (19)

2023

  1. "What medical students with better academic results do: a cross-sectional analysis"

    BMC medical education, Vol. 23, Núm. 1, pp. 19

  2. Delays to surgery following chemoradiotherapy lead to poorer oncologic outcomes in patients with localized pancreatic adenocarcinoma

    Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 8, pp. 428-434

  3. Impact of perineural invasion on the outcome of patients with synchronous colorectal liver metastases treated with neoadjuvant chemotherapy and surgery

    Clinical and Translational Oncology, Vol. 25, Núm. 8, pp. 2523-2531

  4. Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinoma

    Pancreatology, Vol. 23, Núm. 4, pp. 411-419

2019

  1. Neoadjuvant therapy for locally advanced gastric cancer patients. A population pharmacodynamic modeling

    PLoS ONE, Vol. 14, Núm. 5

  2. Use of machine-learning algorithms in intensified preoperative therapy of pancreatic cancer to predict individual risk of relapse

    Cancers, Vol. 11, Núm. 5

2018

  1. Intensified neoadjuvant multimodal approach in synchronous liver metastases from gastric cancer: a single institutional experience

    Clinical and Translational Oncology, Vol. 20, Núm. 5, pp. 658-665

2016

  1. Clinical significance of cellular and acellular mucin pools in rectal carcinoma following preoperative chemoradiotherapy

    Clinical and Translational Oncology, Vol. 18, Núm. 7, pp. 714-721

  2. Patterns and management of distant failure in locally advanced rectal cancer: a cohort study

    Clinical and Translational Oncology, Vol. 18, Núm. 9, pp. 909-914

  3. Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer

    British Journal of Cancer, Vol. 115, Núm. 6, pp. 655-663

2015

  1. Impact of Perineural and Lymphovascular Invasion on Oncological Outcomes in Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy and Surgery

    Annals of Surgical Oncology, Vol. 22, Núm. 3, pp. 916-923

  2. Long-term oncologic results in cancer of the rectum treated by preoperative chemoradiotherapy and surgery: An analysis of 500 cases

    Revista Espanola de Enfermedades Digestivas, Vol. 107, Núm. 6, pp. 340-346

2013

  1. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy

    Diseases of the Colon and Rectum, Vol. 56, Núm. 4, pp. 416-421

2012

  1. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial

    International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593

2011

  1. Accuracy of endoscopic ultrasound to assess tumor response after neoadjuvant treatment in rectal cancer: Can we trust the findings?

    Diseases of the Colon and Rectum, Vol. 54, Núm. 9, pp. 1141-1146

  2. Patterns of response after preoperative treatment in gastric cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 80, Núm. 3, pp. 698-704

  3. Portal pneumatosis as a complication of neoadjuvant chemoradiotherapy for rectal cancer: A case report

    Colorectal Disease, Vol. 13, Núm. 11

2008

  1. Phase I-II Trial of Concurrent Capecitabine and Oxaliplatin With Preoperative Intensity-Modulated Radiotherapy in Patients With Locally Advanced Rectal Cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 71, Núm. 3, pp. 748-755

2002

  1. Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer

    British Journal of Cancer, Vol. 87, Núm. 2, pp. 158-160